EDGAR Filing Documents for 0001213900-15-007373

Form 8-K - Current report:

SEC Accession No. 0001213900-15-007373

Filing Date

2015-09-30

Accepted

2015-09-30 09:10:47

Documents

Period of Report

2015-09-24

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	f8k092415_optimizerx.htm	8-K	31713
2	STOCK PURCHASE AGREEMENT	f8k092415ex10i_optimizerx.htm	EX-10.1	269185
3	INVESTORS RIGHT AGREEMENT	f8k092415ex10ii_optimizerx.htm	EX-10.2	164062
4	INDEMNITY AGREEMENT	f8k092415ex10iii_optimizerx.htm	EX-10.3	39029
5	PRESS RELEASE	f8k092415ex99i_optimizerx.htm	EX-99.1	10181
	Complete submission text file	0001213900-15-007373.txt		515518

Mailing Address 400 WATER ST., STE. 200 ROCHESTER MI 48307

Business Address 400 WATER ST., STE. 200 ROCHESTER MI 48307 248-651-6558

OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)